Merus Labs International Inc. (TSE:MSL – Free Report) (NASDAQ:MSLI) – Stock analysts at HC Wainwright issued their Q1 2024 earnings estimates for Merus Labs International in a research report issued to clients and investors on Monday, April 15th. HC Wainwright analyst A. He anticipates that the specialty pharmaceutical company will post earnings per share of ($0.05) for the quarter. HC Wainwright currently has a “Buy” rating on the stock. HC Wainwright also issued estimates for Merus Labs International’s Q2 2024 earnings at ($0.05) EPS, Q3 2024 earnings at ($0.05) EPS, Q4 2024 earnings at ($0.05) EPS, FY2024 earnings at ($0.19) EPS, Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at ($0.05) EPS, Q3 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.20) EPS, FY2026 earnings at ($0.18) EPS, FY2027 earnings at ($0.23) EPS and FY2028 earnings at ($0.22) EPS.
Merus Labs International Stock Performance
The stock has a fifty day simple moving average of C$1.65. Merus Labs International has a 1-year low of C$0.95 and a 1-year high of C$1.76.
Merus Labs International Company Profile
Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin.
Featured Articles
- Five stocks we like better than Merus Labs International
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Comprehensive PepsiCo Stock Analysis
- Overbought Stocks Explained: Should You Trade Them?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- The 3 Best Retail Stocks to Shop for in August
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Merus Labs International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International and related companies with MarketBeat.com's FREE daily email newsletter.